PHARMACOKINETIC INTERACTIONS BETWEEN DIGOXIN AND OTHER DRUGS

被引:74
作者
MARCUS, FI
机构
关键词
D O I
10.1016/S0735-1097(85)80466-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A82 / A90
页数:9
相关论文
共 104 条
  • [1] INFLUENCE OF KAOLIN-PECTIN SUSPENSION ON DIGOXIN BIOAVAILABILITY
    ALBERT, KS
    AYRES, JW
    DISANTO, AR
    WEIDLER, DJ
    SAKMAR, E
    HALLMARK, MR
    STOLL, RG
    DESANTE, KA
    WAGNER, JG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) : 1582 - 1586
  • [2] EFFECT OF MAGNESIUM-ALUMINUM HYDROXIDE AND KAOLIN-PECTIN ON ABSORPTION OF DIGOXIN FROM TABLETS AND CAPSULES
    ALLEN, MD
    GREENBLATT, DJ
    HARMATZ, JS
    SMITH, TW
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (01) : 26 - 30
  • [3] RIFAMPIN DRUG-INTERACTIONS
    BACIEWICZ, AM
    SELF, TH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (08) : 1667 - 1671
  • [4] INTERACTION BETWEEN DIGOXIN AND CALCIUM-ANTAGONISTS AND ANTI-ARRHYTHMIC DRUGS
    BELZ, GG
    DOERING, W
    MUNKES, R
    MATTHEWS, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) : 410 - 417
  • [5] BINNION PF, 1973, S DIGITALIS, P216
  • [6] BROWN DD, 1976, CLIN PHARMACOL THER, V20, P395
  • [7] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO ANTACIDS AND KAOLIN-PECTIN
    BROWN, DD
    JUHL, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (19) : 1034 - 1037
  • [8] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO HYPOCHOLESTEROLEMIC INTERVENTIONS
    BROWN, DD
    JUHL, RP
    WARNER, SL
    [J]. CIRCULATION, 1978, 58 (01) : 164 - 172
  • [9] DRUG-INTERACTIONS WITH DIGOXIN
    BROWN, DD
    SPECTOR, R
    JUHL, RP
    [J]. DRUGS, 1980, 20 (03) : 198 - 206
  • [10] THE INFLUENCE OF RIFAMPIN ON QUINIDINE AND DIGOXIN
    BUSSEY, HI
    MERRITT, GJ
    HILL, EG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (05) : 1021 - 1023